Cargando…
A Comparative Evaluation of Hydroxycamptothecin Drug Nanorods With and Without Methotrexate Prodrug Functionalization for Drug Delivery
We developed a novel self-targeted multi-drug co-delivery system based on rod-shaped 10-hydroxycamptothecin (CPT) nanoanticancer drug (CPT NRs) followed by a surface functionalization with self-targeting PEGylated lipid-conjugated methotrexate (MTX) pro-anticancer drug. The self-targeting effect and...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5007229/ https://www.ncbi.nlm.nih.gov/pubmed/27581601 http://dx.doi.org/10.1186/s11671-016-1599-y |
_version_ | 1782451172122034176 |
---|---|
author | Guo, Fuqiang Fan, Zhongxiong Yang, Jinbin Li, Yang Wang, Yange Zhao, Hai Xie, Liya Hou, Zhenqing |
author_facet | Guo, Fuqiang Fan, Zhongxiong Yang, Jinbin Li, Yang Wang, Yange Zhao, Hai Xie, Liya Hou, Zhenqing |
author_sort | Guo, Fuqiang |
collection | PubMed |
description | We developed a novel self-targeted multi-drug co-delivery system based on rod-shaped 10-hydroxycamptothecin (CPT) nanoanticancer drug (CPT NRs) followed by a surface functionalization with self-targeting PEGylated lipid-conjugated methotrexate (MTX) pro-anticancer drug. The self-targeting effect and in vitro cell viability of the MTX-PEG-CPT NRs on HeLa cells were demonstrated by comparative cellular uptake and MTT assay of the PEG-CPT NRs. In vitro studies showed the feasibility of using this high drug-loading MTX-PEG-CPT NRs in self-targeted drug delivery, controlled-/sustained-release, and synergistic cancer therapy. More importantly, this work would stimulate interest in the use of PEGylated lipid-conjugated MTX by introducing an early-phase tumor-targeting role and then driving a late-phase anticancer role for the highly convergent design of nanomulti-drug, which may advantageously offer a new and simple strategy for simultaneously targeting and treating FA receptor-overexpressing cancer cells. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s11671-016-1599-y) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-5007229 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Springer US |
record_format | MEDLINE/PubMed |
spelling | pubmed-50072292016-09-22 A Comparative Evaluation of Hydroxycamptothecin Drug Nanorods With and Without Methotrexate Prodrug Functionalization for Drug Delivery Guo, Fuqiang Fan, Zhongxiong Yang, Jinbin Li, Yang Wang, Yange Zhao, Hai Xie, Liya Hou, Zhenqing Nanoscale Res Lett Nano Express We developed a novel self-targeted multi-drug co-delivery system based on rod-shaped 10-hydroxycamptothecin (CPT) nanoanticancer drug (CPT NRs) followed by a surface functionalization with self-targeting PEGylated lipid-conjugated methotrexate (MTX) pro-anticancer drug. The self-targeting effect and in vitro cell viability of the MTX-PEG-CPT NRs on HeLa cells were demonstrated by comparative cellular uptake and MTT assay of the PEG-CPT NRs. In vitro studies showed the feasibility of using this high drug-loading MTX-PEG-CPT NRs in self-targeted drug delivery, controlled-/sustained-release, and synergistic cancer therapy. More importantly, this work would stimulate interest in the use of PEGylated lipid-conjugated MTX by introducing an early-phase tumor-targeting role and then driving a late-phase anticancer role for the highly convergent design of nanomulti-drug, which may advantageously offer a new and simple strategy for simultaneously targeting and treating FA receptor-overexpressing cancer cells. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s11671-016-1599-y) contains supplementary material, which is available to authorized users. Springer US 2016-08-31 /pmc/articles/PMC5007229/ /pubmed/27581601 http://dx.doi.org/10.1186/s11671-016-1599-y Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Nano Express Guo, Fuqiang Fan, Zhongxiong Yang, Jinbin Li, Yang Wang, Yange Zhao, Hai Xie, Liya Hou, Zhenqing A Comparative Evaluation of Hydroxycamptothecin Drug Nanorods With and Without Methotrexate Prodrug Functionalization for Drug Delivery |
title | A Comparative Evaluation of Hydroxycamptothecin Drug Nanorods With and Without Methotrexate Prodrug Functionalization for Drug Delivery |
title_full | A Comparative Evaluation of Hydroxycamptothecin Drug Nanorods With and Without Methotrexate Prodrug Functionalization for Drug Delivery |
title_fullStr | A Comparative Evaluation of Hydroxycamptothecin Drug Nanorods With and Without Methotrexate Prodrug Functionalization for Drug Delivery |
title_full_unstemmed | A Comparative Evaluation of Hydroxycamptothecin Drug Nanorods With and Without Methotrexate Prodrug Functionalization for Drug Delivery |
title_short | A Comparative Evaluation of Hydroxycamptothecin Drug Nanorods With and Without Methotrexate Prodrug Functionalization for Drug Delivery |
title_sort | comparative evaluation of hydroxycamptothecin drug nanorods with and without methotrexate prodrug functionalization for drug delivery |
topic | Nano Express |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5007229/ https://www.ncbi.nlm.nih.gov/pubmed/27581601 http://dx.doi.org/10.1186/s11671-016-1599-y |
work_keys_str_mv | AT guofuqiang acomparativeevaluationofhydroxycamptothecindrugnanorodswithandwithoutmethotrexateprodrugfunctionalizationfordrugdelivery AT fanzhongxiong acomparativeevaluationofhydroxycamptothecindrugnanorodswithandwithoutmethotrexateprodrugfunctionalizationfordrugdelivery AT yangjinbin acomparativeevaluationofhydroxycamptothecindrugnanorodswithandwithoutmethotrexateprodrugfunctionalizationfordrugdelivery AT liyang acomparativeevaluationofhydroxycamptothecindrugnanorodswithandwithoutmethotrexateprodrugfunctionalizationfordrugdelivery AT wangyange acomparativeevaluationofhydroxycamptothecindrugnanorodswithandwithoutmethotrexateprodrugfunctionalizationfordrugdelivery AT zhaohai acomparativeevaluationofhydroxycamptothecindrugnanorodswithandwithoutmethotrexateprodrugfunctionalizationfordrugdelivery AT xieliya acomparativeevaluationofhydroxycamptothecindrugnanorodswithandwithoutmethotrexateprodrugfunctionalizationfordrugdelivery AT houzhenqing acomparativeevaluationofhydroxycamptothecindrugnanorodswithandwithoutmethotrexateprodrugfunctionalizationfordrugdelivery AT guofuqiang comparativeevaluationofhydroxycamptothecindrugnanorodswithandwithoutmethotrexateprodrugfunctionalizationfordrugdelivery AT fanzhongxiong comparativeevaluationofhydroxycamptothecindrugnanorodswithandwithoutmethotrexateprodrugfunctionalizationfordrugdelivery AT yangjinbin comparativeevaluationofhydroxycamptothecindrugnanorodswithandwithoutmethotrexateprodrugfunctionalizationfordrugdelivery AT liyang comparativeevaluationofhydroxycamptothecindrugnanorodswithandwithoutmethotrexateprodrugfunctionalizationfordrugdelivery AT wangyange comparativeevaluationofhydroxycamptothecindrugnanorodswithandwithoutmethotrexateprodrugfunctionalizationfordrugdelivery AT zhaohai comparativeevaluationofhydroxycamptothecindrugnanorodswithandwithoutmethotrexateprodrugfunctionalizationfordrugdelivery AT xieliya comparativeevaluationofhydroxycamptothecindrugnanorodswithandwithoutmethotrexateprodrugfunctionalizationfordrugdelivery AT houzhenqing comparativeevaluationofhydroxycamptothecindrugnanorodswithandwithoutmethotrexateprodrugfunctionalizationfordrugdelivery |